Following the performance of the 1st pediatric bone marrow allograft in Morocco of a patient with Fanconi’s disease, the Cheikh Khalifa International University Hospital is organizing a scientific day on March 10, 2022 for all health professionals. to come back to this experience and explain the different aspects of this intervention which is a first in the national context.
Fanconi’s disease is a rare genetic disease, of autosomal recessive transmission, with an estimated incidence at birth of 1/160,000. It owes its name to the Swiss pediatrician Guido Fanconi, the first doctor to describe it in 1927 This pathology, whose symptoms appear during the first decade of life, exposes you to many serious complications such as myelodysplastic syndrome or acute leukemia. Allogeneic bone marrow transplantation is the only curative treatment for Fanconi disease.
The Cheikh Khalifa International University Hospital, through its multidisciplinary teams, performed the first bone marrow allograft in Morocco for a 12-year-old girl suffering from Fanconi’s disease. A complex intervention, burdened with heavy morbidity and mortality, due to the characteristics of this condition, and requiring increased multidisciplinary collaboration. These patients are at higher risk of mucosal toxicity and GvH disease (graft versus host disease). GvH being the main cause of graft rejection.
It is in this sense that a scientific day will be organized on March 10, 2022 to present the different stages of the intervention as well as its specificities, and to open the discussion around this clinical case, the first to benefit from an allograft of bone marrow in Morocco as part of the management of this pathology. This event, open to all health professionals, will be an opportunity for debate and exchange to discuss the multidisciplinary management of Fanconi’s disease and allograft bone marrow as a radical treatment.
.
